They don't have to pay off debt. It can be refinanced. This takes place at hundreds of companies every year.
This is only an advisory vote - it has no real effect. Even if they vote for Britain to exit, the lawmakers will just modify the conditions of staying and nothing will change (other than accepting refugees). This is much ado about nothing.. I expect market to rally once reality hits.
This is absolutely wrong thing to do. The stock is worth at least $45 right now. They are in talks right now. What happens if a buyout offer comes this week or next? You will make pennies on the dollar! Just hold your position and it will go to $45 or more, either very quickly or over the next 6 months, meaning you will make $23 a share.(double your money or more from here) Why would you want to be an idiot and only make $7.35? I've had 2 stocks that popped in the last 2 weeks and one went up over 70% and the other over 112%. Both of them had almost the exact same comments you see on this board (BK, debtors foreclosing, no pricing power, etc.). The news that pushed them up was minimal at best. You people forget that current stock price reflects only the mindset of the last idiots that sold - it has nothing to do with reality or the value of the company.
Ha, Ha, LOL. I'm sure he bought all those options and rolled them out so he could do a quick bankruptcy and just lose all that money! LOL The idiocy of you shorts is just amazing.
Bill Miller will make lots of money with VRX. This stock is worth $45 right here, right now. The short sellers that beat it down must cover and they will drive it back up and buyers will come back in. Just because crooks like Cramer and Motley Fool have attacked it means nothing, other than that the price is currently depressed. It will not last at this price.
FDA approved Chantix and it had black box suicide warning label and hit annual sales of $843 million. Its sales have only fallen because of studies finding it was no better than nicotine patches.
They have $60-70 Billion in assets they bought (plus origional value of company). In a firesale they'd get $45 billion. Subtract all $31 billion = $14 billion with no debt. That's twice the market cap and accounts for no cash flow! It's a no-brainer to go long. You have no brain if you are short!
Motley fool article is written by a total idiot - he has little to no figures and assumes it will trade at less than 1 times revenues after most debt gone. Most pharmas trade at 4-5 times revenues (AGN is at 5.7 times revenues). Using his sales and EBITDA figures and comparing to other companies, the share price should be above $60 - but he somehow concluded it should be in teens! It was obvious hit piece.
Capitulation was on June 7, when it traded 103,904,000 shares and hit low at $22.52. This is just excess piling on by Cramer fools and Motley fools. They will get burned here. I've seen this movie many times before.
I believe they will make another takeover offer at this beaten down stock price. It was rumored that the April offer was at $45 a share.
Shares in Takeda Pharmaceutical and Valeant Pharmaceuticals rose amid chatter that the Japanese drugmaker and TPG, the private equity firm, had made a takeover offer for its besieged Canadian peer.
Valeant this spring rejected an approach from its Japanese rival and TPG, according to the Wall Street Journal, before the recent instalment of Joseph Papa as chief executive officer.
They would eliminate a competitor and could greatly cut duplicate staff and GSA expenses, plus DANG trades at only .31 times sales and 3.25 times book while VIPS is priced at 1.16 times sales and 13 times book - DANG would be a huge bargain to them and instantly accretive .
Under the Proposal, iMeigu will acquire all the outstanding Shares and ADSs of the Company in cash for US$8.8 per ADS or US$1.76 per Share (the "Transaction"). It represents a highly attractive premium of approximately 12.6% to the previous preliminary non-binding proposal from Ms. Peggy Yu Yu, Chairwoman of the Board, and Mr. Guoqing Li, director and Chief Executive Officer of the Company (together, the " Insider Buyer ") dated July 9, 2015, to acquire all of the outstanding ordinary shares of the Company not already beneficially owned by the Insider Buyer for $7.812 in cash per ADS.
Yes, I calculated that it would go up .34 cents off the low (but I thought at at the time that .43 was the low). I also only used a medium sampling. I've been working on something extremely complex since then and still am. Math is a wonderful thing.
Huh? I'm not talking about just one day - I'm talking about every day that the volume is above average (and many days where it isn't). The stock goes way up (2.5% or more) from the low of the day to the close. That day was just an extreme example where it closed up 7.5%!
I shouldn't have said new low - I should have said a low lower than the day before on above average volume, it then closes 2.5% or more above the low, breaking through the new resistance. Even on average or below average volume days, it always closes above the low. I think the reason shorts must get out each day is that they fear the Chinese buyout, which they should, because my sources say it is going to happen - that's why I'm in. The Chinese need this company just like the Koreans need Samsung.
Every day that it hits a new low on higher volume, it then closes way up. I went back through all the historical data, and it holds every time. Just one example is on Jan 20, 2016 after hitting low of 9.31 for the day, it then closed at 10.05. It doesn't obey breakdowns though support - it reverses right through that resistance and always closes above it. Looks like a lot of shorts trading this always want out before end of day. This is a great trading vehicle.
First, Collegium barely has enough money to take care of itself for next 18 months, let alone promote someone else's drug. If this deal were with a big Pharma company it would be wonderful but with this pipsqueak it is totally stupid. BDSI just sold their future (because they are running out of cash) for a few shekels that they'll burn in less than a month. Management should have just severly cut expenses and partnered the drug with someone that has a strong sales force and lots of money. Sell into any pop if you have a brain in your skull. All these idiots worry about is their options. One of worst managements I've ever seen.
Try 7.5 times the market cap of OREX, which is absolutely absurd. I bought the close. Thank you to everyone that gave me Christmas in May. Rest assured that your shares are now in strong hands. Special thanks to Spencer Osborne for his uninformed hit piece.